Eisai
4523.T
#2184
Rank
NZ$14.65 B
Marketcap
NZ$51.93
Share price
0.11%
Change (1 day)
3.67%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$2.76 Billion

According to Eisai's latest financial reports the company's total debt is NZ$2.76 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Eisai - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2025-03-31NZ$2.20 B25.43%
2024-03-31NZ$1.75 B16.47%
2023-03-31NZ$1.51 B34.34%
2022-03-31NZ$1.12 B-3.29%
2021-03-31NZ$1.16 B-17.32%
2020-03-31NZ$1.40 B-23.34%
2019-03-31NZ$1.83 B-18.53%
2018-03-31NZ$2.25 B-17.72%
2017-03-31NZ$2.73 B4.6%
2016-03-31NZ$2.61 B-1%
2015-03-31NZ$2.64 B-4.3%
2014-03-31NZ$2.76 B-30.57%
2013-03-31NZ$3.97 B-21.67%
2012-03-31NZ$5.07 B-15.27%
2011-03-31NZ$5.99 B-2.9%
2010-03-31NZ$6.16 B-18.16%
2009-03-31NZ$7.53 B49.82%
2008-03-31NZ$5.03 B179560.65%
2007-03-31NZ$2.8 M-51.65%
2006-03-31NZ$5.79 M-46.8%
2005-03-31NZ$10.88 M294.8%
2004-03-31NZ$2.75 M413.98%
2003-03-31NZ$0.53 M-99.52%
2002-03-31NZ$0.11 B-29.32%
2001-03-31NZ$0.15 B-54.76%
2000-03-31NZ$0.34 B